Is Novo Nordisk (NVO) Stock a Solid Choice Right Now?

One stock that might be an intriguing choice for investors right now is Novo Nordisk A/S NVO. This is because this security in the Large Cap Pharmaceuticals space is seeing solid earnings estimate revision activity, and is in great company from a Zacks Industry Rank perspective.

This is important because, often times, a rising tide will lift all boats in an industry, as there can be broad trends taking place in a segment that are boosting securities across the board. This is arguably taking place in the Large Cap Pharmaceuticals space as it currently has a Zacks Industry Rank of 46 out of more than 250 industries, suggesting it is well-positioned from this perspective, especially when compared to other segments out there.

Meanwhile, Novo Nordisk is actually looking pretty good on its own too. The firm has seen solid earnings estimate revision activity over the past month, suggesting analysts are becoming a bit more bullish on the firm’s prospects in both the short and long term.

Novo Nordisk A/S Price and Consensus

Novo Nordisk A/S Price and Consensus | Novo Nordisk A/S Quote

In fact, over the past month, current quarter estimates have risen from 54 cents per share to 56 cents per share, while current year estimates have risen from $2.26 per share to $2.31 per share. This has helped NVO to earn a Zacks Rank #2 (Buy), further underscoring the company’s solid position. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

So, if you are looking for a decent pick in a strong industry, consider Novo Nordisk. Not only is its industry currently in the top third, but it is seeing solid estimate revisions as of late, suggesting it could be a very interesting choice for investors seeking a name in this great industry segment.

Will You Make a Fortune on the Shift to Electric Cars?

 Here's another stock idea to consider. Much like petroleum 150 years ago, lithium power may soon shake the world, creating millionaires and reshaping geo-politics. Soon electric vehicles (EVs) may be cheaper than gas guzzlers. Some are already reaching 265 miles on a single charge.

With battery prices plummeting and charging stations set to multiply, one company stands out as the #1 stock to buy according to Zacks research.

It's not the one you think.

See This Ticker Free >>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Novo Nordisk A/S (NVO) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research